• HOME
  • ABOUT US
    • WHO WE ARE
    • OUR MISSION
    • TEAM & PARTNERS
  • PROJECTS
    • RESEARCH & DEVELOPMENT
    • PRODUCTS
    • TECHNOLOGIES FOR TRANSFER
  • NEWS
    • NEWS & MEDIA
    • BLOG
  • CONTACT
  • LinkedIn
COVID-19 DIAGNOSTICS
  • HOME
  • ABOUT US
    • WHO WE ARE
    • OUR MISSION
    • TEAM & PARTNERS
  • PROJECTS
    • RESEARCH & DEVELOPMENT
    • PRODUCTS
    • TECHNOLOGIES FOR TRANSFER
  • NEWS
    • NEWS & MEDIA
    • BLOG
  • CONTACT
  • LinkedIn

Severity Predictor

Prediction of symptom severity of infectious diseases days before their manifestation.

Diagnostics of Kidney Diseases

Detection of MUC1 protein in biological samples for diagnostic use.

Prediction of Pregnancy Complications

Prediction of onset of various pregnancy complications during first-trimester screening.

HIV Treatment

New application of heme arginate for treatment of HIV infections.

Lab-On-Chip

Novel passive system for sample work-up and analyte detection.

Dry Blood Spot

Complex solution for diagnostics for various genetic disorders using dry-blood-spot sampling.

Human NGS Diagnostics

Universal tools for diagnostics of genetic disorders based on next generation sequencing.

Collection Systems

Tools for collecting biological samples via nasopharyngeal swabs and from saliva.

Nucleic Acid Extraction

Tools for high-efficient isolation of nucleic acids from biological samples.

Adsorption Surfaces and Nanostructures

Portfolio of products focused on tailored adsorption of target analytes for diagnostic use.

SARS-CoV-2 Sequencing

Universal tools for sequencing of genome of SARS-CoV-2 and other pathogens.

COVID-19 Treatment

New application of heme arginate for treatment of SARS-CoV-2 infections.

Putting Rapid Clinical Results into the Hands of Patients

Putting Rapid Clinical Results into the Hands of Patients

by admin | Jan 18, 2023 | News from Genespector

The timely and accurate diagnosis of disease is necessary for treatments that maximize the patients’ survival and quality of life. For this, an ever-growing number of disease-related biomarkers is monitored, usually with expensive instruments. These tests may not be...
Saving Lives Months Ahead: Prediction of Risk of Pregnancy Complications

Saving Lives Months Ahead: Prediction of Risk of Pregnancy Complications

by admin | Jan 18, 2023 | News from Genespector

Complications in pregnancy affect 5 to 10% of women and can not only threaten the life or health of the mother and her child, but also cause irreversible changes in their metabolism and cardiovascular and cerebrovascular systems. However, current methods can only...
Novel NGS Assay: Making Myeloma Detection and Monitoring Accessible for any Laboratory in the World

Novel NGS Assay: Making Myeloma Detection and Monitoring Accessible for any Laboratory in the World

by admin | Jan 18, 2023 | News from Genespector

Multiple myeloma is a plasma cell disorder. It is a malignant disease caused by uncontrolled clonal proliferation of these cells in the bone marrow, leading to serious bone destruction.The disease develops in a very creeping manner and is detected at an early stage...
Enhancing Clinical Diagnostics with Smart Nanostructures

Enhancing Clinical Diagnostics with Smart Nanostructures

by admin | Jan 18, 2023 | News from Genespector

Using smart nanostructures in clinical diagnostics is a joint project between us and IQS nano. IQS nano is a company developing smart technologies which are used in diverse fields such as lighting, biomedical devices or microchips. We believe that this collaboration...
Simplifying the Lab Flow in Molecular Diagnostics

Simplifying the Lab Flow in Molecular Diagnostics

by admin | Jan 18, 2023 | News from Genespector

We are bringing the simplicity to the diagnostic lab. Analysis of genetic material is one of the key tools used in routine clinical diagnostics. The first essential step of such analyses involves extraction of nucleic acids from a given source material. Commonly...

Recent Posts

  • Putting Rapid Clinical Results into the Hands of Patients
  • Major Breakthrough in the Fight Against AIDS
  • Saving Lives Months Ahead: Prediction of Risk of Pregnancy Complications
  • Novel NGS Assay: Making Myeloma Detection and Monitoring Accessible for any Laboratory in the World
  • Enhancing Clinical Diagnostics with Smart Nanostructures

Recent Comments

    i

    Media

    Martin Šemík
    PR manager
    martin.semik@surikatapr.cz

    t

    General Queries

    info@genespector.com

    

    Investors

    info@genespector.com

    

    Partners

    info@genespector.com

    Czech Subsidiary

    GeneSpector Innovations s.r.o.
    Petrská 1180/3, Nové Město, 110 00 Prague
    IČO: 10910697
    DIČ: CZ10910697

    US Subsidiary

    GeneSpector Innovations USA, Inc.
    3500 South Dupont Highway, Dover DE 19901

    

    Copyright © 2022 – Genespector Innovations

    ×